Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders
Vyanka Redenbaugh(Mayo Clinic), Eoin P. Flanagan(Mayo Clinic in Arizona), M. Tariq Bhatti, Marina Buciuc(Mayo Clinic), A. Sebastian López‐Chiriboga, Brian G. Weinshenker(Mayo Clinic in Arizona), Andrew McKeon(Mayo Clinic), Vanda A. Lennon(Mayo Clinic), John J. Chen(Mayo Clinic in Arizona), John R. Mills(Mayo Clinic), Elia Sechi(Mayo Clinic), James P. Fryer(Mayo Clinic in Arizona), Dean M. Wingerchuk(WinnMed), Sean J Pittock(Mayo Clinic), Mayra Montalvo(Brown University)
Multiple Sclerosis Journal - Experimental Translational and Clinical
October 1, 2021
Cited by 50
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k